Germline BRCA1 185delAG mutations in Jewish women with breast cancer

Lancet

Volumn 347, Issue 9016, 1996, Pages 1643-1645

  Offit, Kenneth ^a   Gilewski, Teresa ^a   McGuire, Peter ^a   Schluger, Alice ^a   Hampel, Heather ^a   Brown, Karen ^a   Swensen, Jeff ^b   Neuhausen, Susan ^b   Skolnick, Mark ^b,c   Norton, Larry ^a   Goldgar, David ^b,d  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c Myriad Genetic Laboratories   (United States)

^d INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; GUANINE;

ADULT; ARTICLE; BREAST CANCER; FAMILIAL CANCER; FAMILY HISTORY; FEMALE; FRAMESHIFT MUTATION; GENETIC COUNSELING; GENETIC SCREENING; GERM LINE; HUMAN; JEW; MAJOR CLINICAL STUDY; OVARY CANCER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 15844375655     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(96)91484-1     Document Type: Article

References (10)

1. Ford D, Easton DF, Bishop DT, et al. Risks of cancer in BRCA1-mutation carriers. Lancet 1994; 343: 692-95.
2. Shattuck-Eidens D, McClure M, Simard J, et al. A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene: implications for presymptomatic testing and screening. JAMA 1995; 272: 535-41.
3. Simard J, Tonin P, Durocher F, et al. Recurrent mutations of the BRCA1 gene in Canadian breast and ovarian cancer families. Nature Genet 1994; 8: 392-98.
4. Struewing JP, Brody LC, Erdos MR, et al. Detection of eight BRCA1 mutations in 10 breast/ovarian cancer families, including 1 family with male breast cancer. Am J Hum Genet 1995; 57: 1-7.
5. Tonin F, Serova O, Lenoir G, et al. Germline mutation of BRCA1 in Ashkenazi Jewish women. Am J Hum Genet 1995; 57: 189.
6. Struewing JP, Abeliovich D, Peretz T, et al. The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals. Nature Genet 1995; 11: 198-200.
7. Offit K, Brown K. Quantitative risk counselling for familial cancer: a resource for clinical oncologists. J Clin Oncol 1994; 12: 1724-36.
8. Saiki RK, Scharf S, Faloona F, et al. Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science 1985; 230: 1350-54.
9. Mullis K, Faloona F, Scharf F, Saiki R, Horn G, Erlich H. Specific enzymatic amplification of DNA in vitro: the polymerase chain reaction. Cold Spring Harbor Symp Quant Biol 1986; 51: 263-73.
10. Weber JL, May PE. Abundant class of human DNA polymorphism which can be typed using the polymerase chain reaction. Am J Hum Genet 1989; 44: 388-96.